Status:
UNKNOWN
Panmacular Versus Minimal Micropulse Laser Therapy in Central Serous Chorioretinopathy
Lead Sponsor:
Moorfields Eye Hospital Centre Abu Dhabi
Collaborating Sponsors:
University of Warmia and Mazury in Olsztyn
University of Gdansk
Conditions:
Central Serous Chorioretinopathy
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Central serous retinopathy is a disease of poorly understood etiology characterized by accumulation of subretinal fluid and leading to significant decrease in vision. Micropulse laser therapy has been...
Detailed Description
Study Design: This is a comparative, prospective, interventional, multicenter, randomized study of micropulse laser treatment of central serous chorioretinopathy with 2 treatment arms: 1. \< 6 month...
Eligibility Criteria
Inclusion
- CSR diagnosed \< 6 months ago Willingness to undergo micropulse laser treatment and keep follow-up visits
Exclusion
- High myopia Other significant macular disease, other treatment for CSR Pregnancy
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04410861
Start Date
June 1 2020
End Date
January 1 2022
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moorfields Eye Hospital Centre
Abu Dhabi, United Arab Emirates